Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03020017Early Phase 1Completed
NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
GliosarcomaRecurrent Glioblastoma
PrincipalinvestigatorStart date: 2017-05-25
NCT02847559Phase 2Completed
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Anaplastic (Malignant) MeningiomaAtypical MeningiomaGrade II Meningioma+3 more
PrincipalinvestigatorStart date: 2016-08-01
NCT01125046Phase 2Completed
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Acoustic SchwannomaAdult Anaplastic MeningiomaAdult Ependymoma+7 more
PrincipalinvestigatorStart date: 2010-06-17

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Related
6 trials

Shared therapeutic areas:

Adult EpendymomaAdult Grade I MeningiomaAdult Grade II Meningioma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Behnam Badie

City of Hope Medical Center

Related
6 trials

Shared therapeutic areas:

Recurrent GlioblastomaGliosarcomaGrade III Meningioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Recurrent Adult Brain TumorRecurrent Glioblastoma

Worked with same sponsors:

National Cancer Institute (NCI)Northwestern University
Similarity Score3%

Daniel Landi, MD

Duke University

Related
7 trials

Shared therapeutic areas:

GliosarcomaRecurrent Glioblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Ana-Maria Vranceanu, PhD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Neurofibromatosis 2Neurofibromatosis 1
Similarity Score3%

AeRang Kim, MD, PhD

Children's National Research Institute

Related
7 trials

Shared therapeutic areas:

Neurofibromatosis 1
Similarity Score2%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Neurofibromatosis 1

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Neuroma, Acoustic
Similarity Score2%

Jane Robertson

AstraZeneca

Related
10 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score2%

Brigitte C. Widemann, MD

National Cancer Institute (NCI)

Related
6 trials

Shared therapeutic areas:

Neurofibromatosis 1

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03020017Early Phase 1PrincipalInvestigator

NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery

GliosarcomaRecurrent Glioblastoma
Completed
NCT02847559Phase 2PrincipalInvestigator

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Anaplastic (Malignant) MeningiomaAtypical MeningiomaGrade II Meningioma+3 more
Completed
NCT01125046Phase 2PrincipalInvestigator

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Acoustic SchwannomaAdult Anaplastic MeningiomaAdult Ependymoma+7 more
Completed

All 3 trials loaded